Buprenorphine-Naloxone Cost-Effective for Opioid Use Disorder

MONDAY, Dec. 17, 2018 -- Buprenorphine-naloxone is cost-effective compared with extended-release naltrexone for treating opioid use disorder, according to a study published online Dec. 18 in the Annals of Internal Medicine. Sean M. Murphy, Ph.D.,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news